XOMAPライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:09):

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health...

Stats
本日の出来高	1 005.00
平均出来高	1 383.00
時価総額	289.31M
EPS	$-0.480 ( 2023-09-29 )
Last Dividend	$0.539 ( 2023-10-04 )
Next Dividend	$0 ( N/A )
P/E	24.86
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-08	Hughes Owen	Buy	275 000	Performance Stock Units
2023-10-03	Sitko Bradley	Buy	250	Common Stock
2023-10-02	Sitko Bradley	Buy	1 500	Common Stock
2023-10-02	Hughes Owen	Buy	1 000	Common Stock
2023-09-26	Hughes Owen	Buy	2 499	Common Stock

INSIDER POWER
100.00
Last 90 transactions
Buy: 3 445 824 \| Sell: 117 506

XOMA Corporation 相関

10 最も正の相関
RNEM	0.944
IVAC	0.943
SCZ	0.939
RNDM	0.939
NECB	0.939
IDLB	0.938
ISDX	0.936
VYMI	0.935
KE	0.935
RFDI	0.935

10 最も負の相関
LYRA	-0.943
IMRX	-0.936
LYEL	-0.935
STRC	-0.935
NKTX	-0.933
NUWE	-0.932
GRNV	-0.931
SWVL	-0.931
ONCS	-0.93
GROM	-0.929

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

XOMA Corporation 財務諸表

Annual	2023
収益:	$4.76M
総利益:	$3.86M (81.08 %)
EPS:	$-3.56

FY	2023
収益:	$4.76M
総利益:	$3.86M (81.08 %)
EPS:	$-3.56

FY	2022
収益:	$6.03M
総利益:	$5.93M (98.39 %)
EPS:	$-1.500

FY	2021
収益:	$38.16M
総利益:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

XOMA Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.539 (N/A)	$0 (N/A)	$0.539 (N/A)	$1.078 (N/A)	$0 (N/A)	$0.539 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

XOMA Corporation Dividend Information - Dividend Knight

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.719	2021-03-31
Last Dividend	$0.539	2023-10-04
Next Dividend	$0	N/A
Payout Date	2023-10-16
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$6.11	--
Avg. Dividend % Per Year	5.02%	--
Score	3.62	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-07-15)

$0.550 Estimate 20.00 %

Dividend Stability

0.53 Average

Dividend Score

3.62

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2021	$1.797	7.14%
2022	$2.16	8.31%
2023	$2.16	8.82%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-10.24	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.208	1.200	-6.93	-8.32	[0 - 0.3]
returnOnEquityTTM	-0.465	1.500	-6.28	-9.42	[0.1 - 1]
payoutRatioTTM	-0.112	-1.000	-1.123	1.123	[0 - 1]
currentRatioTTM	8.68	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	8.66	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	7.87	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.530	-1.500	1.171	-1.757	[0 - 0.6]
interestCoverageTTM	-130.17	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-1.582	2.00	-0.527	-1.055	[0 - 30]
freeCashFlowPerShareTTM	-2.86	2.00	-1.430	-2.86	[0 - 20]
debtEquityRatioTTM	1.399	-1.500	4.40	-6.61	[0 - 2.5]
grossProfitMarginTTM	0.811	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-5.80	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.146	1.000	-1.924	-1.924	[0.2 - 2]
assetTurnoverTTM	0.0203	0.800	-3.20	-2.56	[0.5 - 2]
Total Score				-1.689

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-5.98	1.000	-0.705	0	[1 - 100]
returnOnEquityTTM	-0.465	2.50	-4.04	-9.42	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.86	2.00	-0.953	-2.86	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.582	2.00	-0.527	-1.055	[0 - 30]
payoutRatioTTM	-0.112	1.500	-1.123	1.123	[0 - 1]
pegRatioTTM	-0.118	1.500	-4.12	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-3.82	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-3.15

XOMA Corporation

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.